Pharvaris
PHVS
31.68
+0.56
+1.80%
Pharvaris
US · PHVS
#2729 by market cap
Listed 2021
31.68
+0.56
+1.80%
Live - 5344 symbols - heartbeat 364s ago
· 2026-10-07 19:54
After-hours
31.68
0.00%
- Market cap
- 2.22B
- P/E (TTM)i
- -10.88
- P/Bi
- 6.60
- EPSi
- -3.33
- Div yieldi
- 0.00%
- 52W posi
- 49%
Reader sentiment
Are you bullish or bearish on PHVS?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 12 analysts
Buy
Avg price target
61.33 +93.6%
Price target rangecurrent 31.68
Low44.00
Avg61.33
High79.00
Buy 92%
Hold 8%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-05 | Morgan Stanley | -- | BUY | 62.00 |
| 2026-09-28 | Morgan Stanley | -- | BUY | 62.00 |
| 2026-09-21 | Morgan Stanley | -- | BUY | 62.00 |
| 2026-09-21 | H.C. Wainwright | -- | BUY | 60.00 |
| 2026-09-14 | Morgan Stanley | -- | BUY | 62.00 |
| 2026-09-10 | Leerink Partners | -- | BUY | 65.00 |
| 2026-09-09 | Cantor Fitzgerald | -- | BUY | 65.00 |
| 2026-09-09 | Wells Fargo | -- | BUY | 65.00 |
| 2026-09-09 | JonesTrading | -- | BUY | 65.00 |
| 2026-09-09 | Wedbush | -- | BUY | 50.00 |
| 2026-09-09 | Citizens JMP | -- | BUY | 79.00 |
| 2026-09-09 | Morgan Stanley | -- | BUY | 62.00 |
| 2026-09-09 | Guggenheim | -- | BUY | 44.00 |
| 2026-09-09 | Leerink Partners | -- | BUY | 65.00 |
| 2026-09-09 | H.C. Wainwright | -- | BUY | 60.00 |
| 2026-09-09 | RBC Capital | -- | BUY | 62.00 |
| 2026-09-08 | BofA Securities | -- | HOLD | 44.00 |
| 2026-09-08 | Morgan Stanley | -- | BUY | 46.00 |
| 2026-09-08 | H.C. Wainwright | -- | BUY | 60.00 |
| 2026-09-08 | Oppenheimer | -- | BUY | 75.00 |
| 2026-08-31 | Morgan Stanley | -- | BUY | 46.00 |
| 2026-08-28 | JonesTrading | -- | BUY | 52.00 |
| 2026-08-24 | Morgan Stanley | -- | BUY | 46.00 |
| 2026-08-14 | H.C. Wainwright | -- | BUY | 60.00 |
| 2026-08-13 | Wells Fargo | -- | BUY | 55.00 |
Quant vs Street three independent views, side by side
StockVane factor grade
B-
Momentum strategy signal
Buy
Analyst consensus
Buy
All 3 views agree: bullish.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.